Related Experiment Videos
[ELISA for detecting antibodies against herpes simplex virus]
Revista Cubana De Medicina Tropical
|April 1, 1991
Summary
This study normalized an indirect ELISA test for herpes simplex virus antibodies, establishing criteria for positive results. The test was validated in immunocompromised patients and blood donors, showing comparable results to immunofluorescence.
Area of Science:
- Immunology
- Virology
- Diagnostic Assay Development
Background:
- Herpes simplex virus (HSV) infections are common, necessitating reliable antibody detection methods.
- Accurate serological assays are crucial for diagnosing HSV infections, especially in immunocompromised individuals.
- Indirect ELISA is a widely used serological technique, but requires standardization for optimal performance.
Purpose of the Study:
- To normalize an indirect Enzyme-Linked Immunosorbent Assay (ELISA) for detecting herpes simplex virus (HSV) antibodies.
- To establish clear conditions and criteria for defining positive results in the standardized ELISA.
- To evaluate the performance of the normalized ELISA by comparing it with an established immunofluorescence technique.
Main Methods:
- Normalization of an indirect ELISA protocol for HSV antibody detection.
- Application of the normalized ELISA to serum samples from 89 immunocompromised patients and 76 blood bank donors.
- Comparative analysis of ELISA results with those obtained from the indirect immunofluorescence technique.
Main Results:
- The indirect ELISA test for HSV antibodies was successfully normalized.
- Specific conditions and criteria for positive test results were established.
- The results from the normalized ELISA showed agreement with the indirect immunofluorescence technique in the tested populations.
Conclusions:
- The normalized indirect ELISA provides a reliable method for detecting HSV antibodies.
- The established criteria ensure accurate interpretation of positive results.
- This standardized assay is suitable for use in clinical settings, including the evaluation of immunocompromised patients.